Spectra for:
Ping Yi, Chad E. Hadden, William F. Annes, David A. Jackson, Barry C. Peterson, Todd A. Gillespie, Jason T. Johnson
Compound M7 LY2419535;DEHYDROGENATED-NAVEGLITAZAR
LY519818;NAVEGLITAZAR;BENZENEPROPANOIC-ACID-ALPHA-METHOXY-4-[3-(4-PHENOXYPHENOXY)-PROPOXY];(S)-ENANTIOMER
![LY519818;NAVEGLITAZAR;BENZENEPROPANOIC-ACID-ALPHA-METHOXY-4-[3-(4-PHENOXYPHENOXY)-PROPOXY];(S)-ENANTIOMER](/api/compound/GycvbGY19hv.png?h=300&w=458 "LY519818;NAVEGLITAZAR;BENZENEPROPANOIC-ACID-ALPHA-METHOXY-4-[3-(4-PHENOXYPHENOXY)-PROPOXY];(S)-ENANTIOMER")
Citation
| Citation | DRUG.MET.DISP.,35,51(2007) |
|---|---|
| Journal | Drug Metabolism and Disposition |
| Issue | 1 |
| Volume | 35 |
| Page(s) | 51-61 |
| Year | 2006 |
| Author(s) | Ping Yi, Chad E. Hadden, William F. Annes, David A. Jackson, Barry C. Peterson, Todd A. Gillespie, Jason T. Johnson |
| Publisher | American Society for Pharmacology & Experimental Therapeutics (ASPET) |
| DOI | 10.1124/dmd.106.012328 |